<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">104</article-id><article-id pub-id-type="doi">10.15690/vramn.v68i12.856</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>РATHOPHYSIOLOGY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ ПАТОФИЗИОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">CURRENT CONCEPTS OF PERINATAL ISCHEMIC INJURY IN THE BRAIN NEUROVASCULAR UNIT: MOLECULAR TARGETS FOR NEUROPROTECTION</article-title><trans-title-group xml:lang="ru"><trans-title>СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ О ПАТОГЕНЕЗЕ ПЕРИНАТАЛЬНОГО ИШЕМИЧЕСКОГО ПОВРЕЖДЕНИЯ КЛЕТОК НЕЙРОВАСКУЛЯРНОЙ ЕДИНИЦЫ ГОЛОВНОГО МОЗГА: МОЛЕКУЛЫ-МИШЕНИ ДЛЯ НЕЙРОПРОТЕКЦИИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Morgun</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Моргун</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, assistant of Pediatric Department of Krasnoyarsk State Medical University. Address: 1, P. Zheleznyak Street, Krasnoyarsk, RF, 660022; tel.: +7 (391) 243-39-52</p></bio><email>441682@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kuvacheva</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Кувачева</surname><given-names>Н. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, associate professor of the Department of Biological Chemistry with the Course of Medical, Pharmaceutical and Toxicological Chemistry of Krasnoyarsk State Medical University. Address: 1, P. Zheleznyak Street, Krasnoyarsk, RF, 660022; tel.: +7 (391) 228-07-69</p></bio><email>natalya.kuvacheva@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Taranushenko</surname><given-names>T. E.</given-names></name><name xml:lang="ru"><surname>Таранушенко</surname><given-names>Т. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, professor, Head of Pediatric Department of Krasnoyarsk State Medical University. Address: 1, P. Zheleznyak Street, Krasnoyarsk, RF, 660022; tel.: +7 (391) 243-39-52</p></bio><email>tetar@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khilazhieva</surname><given-names>E. D.</given-names></name><name xml:lang="ru"><surname>Хилажева</surname><given-names>Е. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>assistant of the Department of Biological Chemistry with the Course of Medical, Pharmaceutical and Toxicological Chemistry of Krasnoyarsk State Medical University Address: 1, P. Zheleznyak Street, Krasnoyarsk, RF, 660022; tel.: +7 (391) 228-07-69</p></bio><email>elena.hilazheva@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Malinovskaya</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Малиновская</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, research scientist of Research Institute of Molecular Medicine and Pathobiochemistry of Krasnoyarsk State Medical University. Address: 1, P. Zheleznyak Street, Krasnoyarsk, RF, 660022; tel.: +7 (391) 228-07-69</p></bio><email>konsuelo81@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gorina</surname><given-names>Ya. V.</given-names></name><name xml:lang="ru"><surname>Горина</surname><given-names>Я. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, senior lecturer of the Department of Biological Chemistry with the Course of Medical, Pharmaceutical and Toxicological Chemistry of Krasnoyarsk State Medical University. Address: 1, P. Zheleznyak Street, Krasnoyarsk, RF, 660022; tel.: +7 (391) 228-07-69</p></bio><email>yana_20@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pozhilenkova</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Пожиленкова</surname><given-names>Е. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, associate professor of the Department of Biological Chemistry with the Course of Medical, Pharmaceutical and Toxicological Chemistry of Krasnoyarsk State Medical University. Address: 1, P. Zheleznyak Street, Krasnoyarsk, RF, 660022; tel.: +7 (391) 228-07-69</p></bio><email>pozhilenkova@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Frolova</surname><given-names>O. V.</given-names></name><name xml:lang="ru"><surname>Фролова</surname><given-names>О. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>research scientist of Research Institute of Molecular Medicine and Pathobiochemistry of Krasnoyarsk State Medical University. Address: 1, P. Zheleznyak Street, Krasnoyarsk, RF, 660022; tel.: +7 (391) 228-07-69</p></bio><email>frolova_olga86@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Salmina</surname><given-names>A. B.</given-names></name><name xml:lang="ru"><surname>Салмина</surname><given-names>А. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, professor, Head of the Department of Biological Chemistry with the Course of Medical, Pharmaceutical and Toxicological Chemistry of Krasnoyarsk State Medical University. Address: 1, P. Zheleznyak Street, Krasnoyarsk, RF, 660022; tel.: +7 (391) 228-07-69</p></bio><email>allasalmina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Krasnoyarsk State Medical University named after Professor V.F. Voino-Yasenetsky, Russian Federation</institution></aff><aff><institution xml:lang="ru">Красноярский государственный медицинский университет им. проф. В.Ф. Войно-Ясенецкого, Российская Федерация</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-12-10" publication-format="electronic"><day>10</day><month>12</month><year>2013</year></pub-date><volume>68</volume><issue>12</issue><issue-title xml:lang="en">Vestnik Rossiiskoi akademii medetsinskikh nauk / Annals of the Russian academy of medical sciences</issue-title><issue-title xml:lang="ru">Вестник Российской академии медицинских наук</issue-title><fpage>26</fpage><lpage>35</lpage><history><date date-type="received" iso-8601-date="2015-08-07"><day>07</day><month>08</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 1970, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 1970, Издательство "Педиатръ"</copyright-statement><copyright-year>1970</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/104">https://vestnikramn.spr-journal.ru/jour/article/view/104</self-uri><abstract xml:lang="en"><p><italic>Perinatal hypoxic-ischemic brain injury is a relevant medical and social problem. Among many pathological processes in the neonatal period perinatal hypoxic-ischemic injury is a major cause of further hemorrhage, necrotic and atrophic changes in the brain. This review presents recent data on the basic mechanisms of the hypoxic-ischemic brain injury along the concept of neurovascular unit (neurons, astrocytes, endothelial cells, pericytes) with the focus on alterations in cell-to-cell communication. Pathological changes caused by ischemia-hypoxia are considered within two phases of injury (ischemic phase and reperfusion phase). The review highlights changes in each individual component of the neurovascular unit and their interactions. Molecular targets for pharmacological improvement of intercellular communication within neurovascular unit as a therapeutic strategy in perinatal brain injury are discussed.</italic></p><p> </p></abstract><trans-abstract xml:lang="ru"><p><italic>Гипоксически-ишемическое поражение головного мозга новорожденного ребенка остается актуальной медицинской и социальной проблемой. Среди множества патологических процессов у новорожденных перинатальные гипоксически-ишемические поражения сами по себе являются основным патогенетическим звеном последующих кровоизлияний, некротических и атрофических изменений головного мозга. В обзоре представлены современные данные об основных механизмах повреждающего гипоксически-ишемического действия на клетки-компоненты нейроваскулярной единицы (нейроны, астроциты, эндотелиоциты, перициты), а также возникающих при этом нарушениях межклеточных взаимодействий. Патологические изменения, развивающиеся в результате гипоксии-ишемии, описаны с учетом наличия двух фаз повреждения (фаза ишемии и фаза реперфузии) и освещаются индивидуальные изменения каждого компонента нейроваскулярной единицы и их взаимодействий. Рассматриваются основные направления фармакологического воздействия на клеточно-молекулярные и патобиохимические механизмы перинатального гипоксически-ишемического повреждения головного мозга.</italic></p></trans-abstract><kwd-group xml:lang="en"><kwd>neurovascular unit</kwd><kwd>intercellular communications</kwd><kwd>perinatal hypoxic-ischemic brain injury</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>нейроваскулярная единица</kwd><kwd>межклеточные взаимодействия</kwd><kwd>перинатальное гипоксически-ишемическое повреждение головного мозга</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1.	Gulamova S.R., Alieva S.A., Nagieva Kh.M., Bagirova A.G. Svit meditsini ta biologii = Light of medicine and biology. 2011; 7(3): 55–58.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2.	Kapranova E.I., Belousova N.A. Doktor.ru = Doktor.ru. 2012; 9: 40–43.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3.	Yanushanets N.Yu. Ros. vestn. perinatologii i pediatrii = Russian bulletin of perinatology and pediatrics. 2006; 51(4): 53–55.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4.	Pal'chik A.B., Shabalov N.P. Gipoksicheski-ishemicheskaya entsefalopatiya novorozhdennykh: Rukovodstvo dlya vrachei [Hypoxic-ischemic Encephalopathy of Newborns: Guideline for Doctors]. St.-Petersburg, Piter, 2006. 224 p.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5.	Mikhalev E.V., Krivonogova T.S., Tropova T.E., Bybchenko E.G., Zhelev V.A. Mat' i ditya v Kuzbasse – Mother and child in Kuzbass. 2011; 4: 40–42.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6.	Platt M.J., Cans C., Johnson A., Surman G., Topp M., Torrioli M.G., Krageloh-Mann I. Trends in cerebral palsy among infants of very low birthweigth (&lt; 1500 g) or born prematurely (&lt; 32 weeks) in 16 European centers: A database study. Lancet. 2007; 369: 43-50.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7.	Baburamani A.A., Ek C.J., Walker D.W., Castillo-Melendez M. Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair? Front. Physiol. 2012; 3: 424.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8.	Vlasyuk V.V. Rodovaya travma i perinatal'nye narusheniya mozgovogo krovoobrashcheniya [Birth Injury and Perinatal Disorders of Cerebral Blood Flow].St.-Petersburg, Nestor-Istoriya, 2009. 252 p.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.	Barashnev Yu.I., Rozanov A.V., Panov V.O., Volobuev A.I. Ros. vestn. perinatologii i pediatrii = Russian bulletin of perinatology and pediatrics. 2006; 51(4): 41–46.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10.	Volpe J.J. The encephalopathy of prematurity – brain injury and impaired brain development inextricably intertwined. Semin. Pediatr. Neurol. 2009; 16 (4): 167-178.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11.	Medvedev M.I., Degtyareva M.G., Gorbunov A.V., Grebennikova O.V., Dulenkov A.B., Voronov V.V. Pediatriya = Pediatrics. 2011; 90(1): 66–70.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12.	Barashnev Yu.I. Perinatal'naya nevrologiya [Perinatal Neurology]. Moscow, Triada-X. 2011. 670 p.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13.	Salmina A.B., Fursov A.A., Mikhutkina S.V., Morgun A.V., Zykova L.D., Musaeva O.F., Fursov M.A., Laletin D.I., Yudin G.V., Trufanova L.V., Shnaider N.A. Sibirskoe meditsinskoe obozrenie = Siberian medical review. 2006; 41(4): 22–27.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14.	Barkovich A.J. Magnetic resonance techniques in the assessment of myelin and myelination. J. Inherit. Metab. Dis. 2005; 28: 311-343.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15.	Ballabh P., Braun A., Nedergaard M. The blood-brain barrier an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 2004; 16: 1-13.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16.	Kuvacheva N.V., Salmina A.B., Komleva Yu.K., Malinovskaya N.A., Morgun A.V., Pozhilenkova E.A., Zamai G.S., Yauzina N.A., Petrova M.M. Zhurnal nevrologii i psikhiatrii im. C.C. Korsakova = S.S. Korsakov Journal of neurology and psychiatry. 2013; 113(4): 80–85.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17.	Fan X., Kavelaars A., Heijnen C.J., Groenendaal F., van Bel F. Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury. Curr. Neuropharmacol. 2010; 8 (4): 324-334.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18.	Iang I., Rozenberg G.A. Stroke. Rossiiskoe izdanie = Stroke. Russian publication. 2012; 1: 91–96.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19.	Salmina A.B., Okuneva O.S., Taranushenko T.E., Fursov A.A., Prokopenko S.V., Mikhutkina S.V., Malinovskaya N.A., Tagaeva G.A. Annaly klinicheskoi i eksperimental'noi nevrologii = Annals of clinical and experimental neurology. 2008; 2(3): 44–51.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20.	Liang J., Takeuchi H., Doi Y., Kawanokuchi J., Sonobe Y., Jin S., Yawata I., Li H., Yasuoka S., Mizuno T., Suzumura A. Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity. Brain Res. 2008; 1210: 11-19.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21.	Uwechue N.M., Marx M.C., Chevy Q., Billups B. Activation of glutamate transport evokes rapid glutamine release from perisynaptic astrocytes. J Physiol. 2012; 590 (Pt 10): 2317-2331.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22.	Weilinger N.L., Tang P.L., Thompson R.J. J. Neurosci. 2012; 32 (36): 12579-12588.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23.	Giaume C., Koulakoff A., Roux L., Holcman D., Rouach N. Nat. Rev. Neurosci. 2010; 11 (2): 87-99.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24.	Iglesias R.M., Spray D.C. Neurochem. Res. 2012; 37 (6): 1355-1363.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25.	Heinrich A., Andó R.D., Túri G., Rózsa B., Sperlágh B. Brit. J. Pharmacol. 2012; 167 (5): 1003-1020.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26.	Minkiewicz J., de Rivero Vaccari J.P., Keane R.W. Glia. 2013; 61 (7): 1113-1121.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27.	Bennett M.V., Garré J.M., Orellana J.A., Bukauskas F.F., Nedergaard M., Sáez J.C. Brain Res. 2012; 1487: 3-15.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28.	Cone A.C., Ambrosi C., Scemes E., Martone M.E., Sosinsky G.E. Front. Pharmacol. 2013; 4: 6.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29.	Franke H., Günther A., Grosche J., Schmidt R., Rossner S., Reinhardt R., Faber-Zuschratter H., Schneider D., Illes P. J. Neuropathol. Exp. Neurol. 2004; 63 (7): 686-699.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>30.	Lai Р.С., Huang Y.T., Wu C.C., Lai C.J., Wang P.J., Chiu T.H. Ceftriaxone attenuates hypoxic-ischemic brain injury in neonatal rats. J. Biomed. Sci. 2011; 18 (1): 69.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>31.	Leibowitz A., Boyko M., Shapira Y., Zlotnik A. Blood glutamate scavenging: insight into neuroprotection. Int. J. Mol. Sci. 2012; 13 (8): 10041-10066.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>32.	Distefano G., Praticò A.D. Actualities on molecular pathogenesis and repairing processes of cerebral damage in perinatal hypoxic-ischemic encephalopathy. Ital. J. Pediatr. 2010; 36: 63.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>33.	Papazisis G., Pourzitaki C., Sardeli C., Lallas A., Amaniti E., Kouvelas D. Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia. Pharmacol. Res. 2008; 57 (1): 73-78.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>34.	Cimino M., Balduini W., Carloni S., Gelosa P., Guerrini U., Tremoli E., Sironi L. Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia. Neurotoxicology. 2005; 26 (5): 929-933.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>35.	Fabian R.H., Perez-Polo J.R., Kent T.A. Perivascular nitric oxide and superoxide in neonatal cerebral hypoxia-ischemia. Am. J. Physiol. Heart. Circ. Physiol. 2008; 295 (4): 1809-1814.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>36.	Loginova I.G., Afonin A.A., Drukker N.A. Sovremennye problemy nauki i obrazovaniya. 2013; 2: 21–29.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>37.	Chekeni F.B., Elliott M.R., Sandilos J.K., Walk S.F., Kinchen J.M., Lazarowski E.R., Armstrong A.J., Penuela S., Laird D.W., Salvesen G.S., Isakson B.E., Bayliss D.A, Ravichandran KS. Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature. 2010; 14 (467): 863-867.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>38.	Bargiotas P., Krenz A., Monyer H., Schwaninger M. Channels (Austin). 2012; 6 (6): 453-456.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>39.	Leonardo C.C., Pennypacker K.R. Neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury. J. Neuroinflamm. 2009; 6: 13.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>40.	Morgun A.V., Ovcharenko N.V., Taranushenko T.E., Ustinova S.I., Okuneva O.S., Antonova S.K., Gilyazova D.F., Uspenskaya O.A., Salmina A.B. Sibirskoe meditsinskoe obozrenie = Siberian medical review. 2013; 3: 3–10.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>41.	Jellema R.K., Lima Passos V., Zwanenburg A., Ophelders D.R., De Munter S., Vanderlocht J., Germeraad W.T., Kuypers E., Collins J.J., Cleutjens J.P., Jennekens W., Gavilanes A.W., Seehase M., Vles H.J., Steinbusch H., Andriessen P., Wolfs T.G., Kramer B.W. Cerebral inflammation and mobilization of the peripheral immune system following global hypoxia-ischemia in preterm sheep. J. Neuroinflammation. 2013; 10: 13.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>42.	Winerdal M., Winerdal M.E., Kinn J., Urmaliya V., Winqvist O., Adén U. Long lasting local and systemic inflammation after cerebral hypoxic ischemia in newborn mice. PLoS One. 2012; 7 (5): 36422.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>43.	Wanqiu Chen, Robert P. Ostrowski, Andre Obenaus, and John H. Zhang Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury. Exp Neurol. 2009; 216 (1): 7-15.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>44.	Salmina A.B., Okuneva O.S., Malinovskaya N.A., Taranushenko T.E., Morgun A.V., Mantorova N.S., Mikhutkina S.V. Neirokhimiya = Neurochemistry. 2008; 25(3): 247–254.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>45.	Salmina A.B., Okuneva O.S., Malinovskaya N.A., Zykova L.D., Fursov A.A., Morgun A.V., Mikhutkina S.V., Taranushenko T.E. Neirokhimiya = Neurochemistry. 2009; 26(3): 237–244.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>46.	Golosnaya G.S., Petrukhin A.S., Krasil'shchikova T.M. Pediatriya = Pediatrics. 2010; 89(1): 20–25.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>47.	Shruster A., Ben-Zur T., Melamed E., Offen D. Wnt signaling enhances neurogenesis and improves neurological function after focal ischemic injury. PLoS One. 2012; 7 (7): e40843.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>48.	Al Haj Zen A, Madeddu P. Notch signalling in ischaemia-induced angiogenesis. Biochem. Soc. Trans. 2009; 37 (Pt 6): 1221-1227.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>49.	Shimada I.S., Borders A., Aronshtam A., Spees J.L. Proliferating reactive astrocytes are regulated by Notch-1 in the peri-infarct area after stroke. Stroke. 2011; 42 (11): 3231-3237.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>50.	del Zoppo G.J. Relationship of neurovascular elements to neuron injury during ischemia. Cerebrovasc. Dis. 2009; 27 (Suppl 1): 65-76.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>51.	Lakhan S.E., Kirchgessner A., Tepper D., Leonard A. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front. Neurol. 2013; 4: 32.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>52.	Scholler K., Trinkl A., Klopotowski M., Thal S. C., Plesnila N., Trabold R., Hamann G.F., Schmid-Elsaesser R., Zausinger S. Characterization of microvascular basal lamina damage and blood-brain barrier dysfunction following subarachnoid hemorrhage in rats. Brain Res. 2007; 1142: 237-246.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>53.	Sen E., Basu A., Willing L.B., Uliasz T.F., Myrkalo J.L., Vannucci S.J., Hewett S.J., Levison S.W. Pre-conditioning induces the precocious differentiation of neonatal astrocytes to enhance their neuroprotective properties. ASN Neuro. 2011; 3 (3): 62.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>54.	Morgun A.V., Malinovskaya N.A., Okuneva O.S., Ustinova S.I., Karpova L.N., Salmina A.B., Pozhilenkova E.A., Laletin D.I., Frolova O.V., Kutishcheva I.A. Ekspressiya P-glikoproteina v kletkakh neirovaskulyarnoi edinitsy pri perinatal'noi gipoksii-ishemii mozga v ostrom periode. Sbornik tezisov dokladov X Vserossiiskoi nauchno-tekhnicheskoi konferentsii «Prioritetnye napravleniya razvitiya nauki i tekhnologii» [Expression of P-glycoprotein in Cells of Neurovascular Unit in Perinatal Cerebral Hypoxia-ischemia in Acute Period. Collection of Abstracts of X Russian Scientific-Technical Conference “Priority Directions of Science and Technology Development”]. Tula, "Innovatsionnye tekhnologii', 2011. pp. 115–116.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>55.	Sizonenko S.V., Camm E.J., Dayer A., Kiss J.Z. Glial responses to neonatal hypoxic-ischemic injury in the rate cerebral cortex. Int. J. Dec. Neurosci. 2008; 26: 37-45.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>56.	Salmina A.B., Malinovskaya N.A., Okuneva O.S., Taranushenko T.E., Fursov A.A., Mikhutkina S.V., Morgun A.V., Prokopenko S.V., Zykova L.D. Byulleten' eksperimental'noi biologii i meditsiny = Bulletin of experimental biology and medicine. 2008; 146(12): 641–645.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>57.	Wang N., De Vuyst E., Ponsaerts R., Boengler K., Palacios-Prado N., Wauman J., Lai C.P., De Bock M., Decrock E., Bol M., Vinken M., Rogiers V., Tavernier J., Evans W.H., Naus C.C., Bukauskas F.F., Sipido K.R., Heusch G., Schulz R., Bultynck G., Leybaert L. Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury. Basic Res. Cardiol. 2013; 108 (1): 309.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>58.	Cowan D.B., Jones M., Garcia L.M., Noria S., del Nido P.J., McGowan F.X. Jr. Arterioscler. Thromb. Vasc. Biol. 2003; 23 (10): 1754-1760.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>59.	Kondo R.P., Wang S.Y., John S.A., Weiss J.N., Goldhaber J.I. J. Mol. Cell Cardiol. 2000; 32 (10): 1859-1872.</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>60.	Davidson J.O., Green C.R., Nicholson L.F., Bennet L., Gunn A.J. Int. J. Mol. Sci. 2012; 13 (5): 6303-6319.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>61.	Zehendner C.M., Librizzi L., de Curtis M., Kuhlmann C.R., Luhmann H.J. Caspase-3 contributes to ZO-1 and Cl-5 tight-junction disruption in rapid anoxic neurovascular unit damage. PLoS One. 2011; 6 (2): e16760.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>62.	Chen F., Ohashi N., Li W., Eckman C., Nguyen J.H. Disruption of occludin and claudin-2 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology. 2009; 50: 1914-1923.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>63.	Won S.M., Lee J.H., Park U.J., Gwag J., Gwag B.J., Lee Y.B. Iron mediates endothelial cell damage and blood-brain barrier opening in the hippocampus after transient forebrain ischemia in rats. Exp. Mol. Med. 2011; 43 (2): 121-128.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>64.	Orellana J.A., von Bernhardi R., Giaume C., Sáez J.C. Glial hemichannels and their involvement in aging and neurodegenerative diseases. Rev. Neurosci. 2012; 23 (2): 163-177.</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>65.	Sawada N., Kim H.H., Moskowitz M.A., Liao J.K. Rac1 is a critical mediator of endothelium-derived neurotrophic activity. Sci. Signal. 2009 Mar 10; 2 (61): doi: 10.1126/scisignal.2000162.</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>66.	Raz L., Zhang Q.G., Zhou C.F., Han D., Gulati P., Yang L.C., Yang F., Wang R.M., Brann D.W. Role of Rac1 GTPase in NADPH oxidase activation and cognitive impairment following cerebral ischemia in the rat. PLoS One. 2010 Sep 7; 5 (9): e12606.</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>67.	Aslam M., Schluter K.D., Rohrbach S., Rafiq A., Nazli S., Piper H.M., Noll T., Schulz R., Gündüz D. Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase. J Physiol. 2013; 591 (Pt 2): 461-73.</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>68.	Liu S., Agalliu D., Yu C., Fisher M. The role of pericytes in blood-brain barrier function and stroke. Curr. Pharm. Des. 2012; 18 (25): 3653-3662.</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>69.	Al Ahmad A., Gassmann M., Ogunshola O.O. Involvement of oxidative stress in hypoxia-induced blood-brain barrier breakdown. Microvasc. Res. 2012; 84 (2): 222-225.</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>70.	Zozulya A., Weidenfeller C., Galla H.J. Pericyte-endothelial cell interaction increases MMP-9 secretion at the blood-brain barrier in vitro. Brain Res. 2008; 1189: 1-11.</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>71.	Ishitsuka K., Ago T., Arimura K., Nakamura K., Tokami H., Makihara N., Kuroda J., Kamouchi M., Kitazono T. Neurotrophin production in brain pericytes during hypoxia: a role of pericytes for neuroprotection. Microvasc. Res. 2012; 83 (3): 352-359.</mixed-citation></ref></ref-list></back></article>
